Endocannabinoid System Changes Across the Menstrual Cycle May Affect Implantation
Key endocannabinoid enzymes in the human uterine lining change expression across the menstrual cycle, with peak levels of degrading enzymes during the implantation window, suggesting endocannabinoid tone drops when embryos need to implant.
Quick Facts
What This Study Found
Researchers mapped endocannabinoid system components in the uterine lining of 49 regularly cycling women. They measured both synthetic enzymes (that produce endocannabinoids) and degrading enzymes (that break them down) across the menstrual cycle.
During the secretory phase (when implantation occurs), the synthetic enzyme NAPE-PLD increased in multiple cell types, while degrading enzymes FAAH and MAGL also increased in glandular tissue. The net effect of simultaneously increasing both production and degradation suggests a tightly controlled endocannabinoid environment during implantation.
COX-2, which oxidizes endocannabinoids, showed maximum expression during the proliferative phase and peaked in luminal cells during early secretory phase.
Key Numbers
49 women; NAPE-PLD increased in luminal (p=0.001), stromal (p=0.007), glandular (p=0.04) cells during secretory phase; FAAH increased in glandular (p=0.009) and luminal (p=0.01) cells; COX-2 peaked in proliferative phase (p=0.002)
How They Did This
Observational study of endometrial biopsies from 49 regularly cycling women. Protein localization by immunohistochemistry and mRNA expression by real-time RT-PCR across menstrual cycle phases.
Why This Research Matters
The endocannabinoid system appears to play a critical role in preparing the uterine lining for embryo implantation. Cannabis use during the implantation window could disrupt this precisely timed system, with implications for fertility.
The Bigger Picture
If the uterine endocannabinoid system must be precisely calibrated for successful implantation, cannabis use could theoretically interfere with fertility by flooding the system with exogenous cannabinoids at the wrong time.
What This Study Doesn't Tell Us
Measured enzyme expression rather than actual endocannabinoid levels. Did not study women using cannabis. Cross-sectional cycle phase comparisons rather than within-subject longitudinal tracking. The functional impact of these expression changes on implantation was not tested.
Questions This Raises
- ?Does cannabis use around the time of implantation reduce fertility?
- ?Could endocannabinoid system testing predict implantation receptivity for IVF?
- ?Would CBD affect these pathways differently than THC?
Trust & Context
- Key Stat:
- Endocannabinoid-degrading enzymes peak during the implantation window
- Evidence Grade:
- Well-designed molecular biology study of human tissue, but observational and did not directly test cannabis effects on implantation.
- Study Age:
- Published in 2015. Reproductive endocannabinoid research has continued to develop.
- Original Title:
- Endocannabinoid regulation in human endometrium across the menstrual cycle.
- Published In:
- Reproductive sciences (Thousand Oaks, Calif.), 22(1), 113-23 (2015)
- Database ID:
- RTHC-01058
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Could cannabis affect fertility?
This study showed the endocannabinoid system in the uterine lining is precisely regulated during the implantation window. Cannabis use could theoretically disrupt this regulation, but the study did not directly test this. Women trying to conceive may want to exercise caution.
What is the implantation window?
It is a brief period during the menstrual cycle when the uterine lining is receptive to embryo attachment. This study found endocannabinoid-degrading enzymes peak during this time, suggesting low endocannabinoid tone may be needed for successful implantation.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-01058APA
Scotchie, Jessica G; Savaris, Ricardo F; Martin, Caitlin E; Young, Steven L. (2015). Endocannabinoid regulation in human endometrium across the menstrual cycle.. Reproductive sciences (Thousand Oaks, Calif.), 22(1), 113-23. https://doi.org/10.1177/1933719114533730
MLA
Scotchie, Jessica G, et al. "Endocannabinoid regulation in human endometrium across the menstrual cycle.." Reproductive sciences (Thousand Oaks, 2015. https://doi.org/10.1177/1933719114533730
RethinkTHC
RethinkTHC Research Database. "Endocannabinoid regulation in human endometrium across the m..." RTHC-01058. Retrieved from https://rethinkthc.com/research/scotchie-2015-endocannabinoid-regulation-in-human
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.